Cancer Drug Targets at CIOC 2027

Cancer drug targets are specific molecules or pathways within cancer cells that scientists aim to inhibit or modify to prevent tumor growth or induce cancer cell death. These targets can vary widely depending on the type of cancer and its genetic makeup. Common targets include proteins involved in cell division, growth factor receptors, and enzymes that support tumor survival. Advances in genomic analysis have led to the identification of new drug targets, allowing for more precise and personalized cancer treatment strategies. Immunotherapy, for example, targets the immune checkpoint proteins that cancer cells exploit to evade detection by the immune system. By understanding and effectively targeting these key molecules, researchers are developing increasingly effective and less toxic treatments for various types of cancer.